# Maintenance Treatment With Capecitabine Metronomic Chemotherapy and Chinese Traditional Medicine in Metastatic Colorectal Cancer

> **NCT02575378** · PHASE4 · UNKNOWN · sponsor: **Ruijin Hospital** · enrollment: 159 (estimated)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Metronimic chemotherapy plus Chinese Traditional Medicine
- **DRUG:** Metronimic chemotherapy

## Key facts

- **NCT ID:** NCT02575378
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2018-06
- **Final completion:** 2018-12
- **Target enrollment:** 159 (ESTIMATED)
- **Last updated:** 2015-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02575378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02575378, "Maintenance Treatment With Capecitabine Metronomic Chemotherapy and Chinese Traditional Medicine in Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02575378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*